This study investigates the impact of immune-type enteral nutrition on key plasma and serum biomarkers – namely immunoglobulins (IgG, IgM, and IgA), nutritional proteins (transferrin, albumin, and prealbumin), and inflammatory markers (IL-6 and C-reactive protein) – in patients undergoing radical colon cancer resection, providing valuable insights into its effects on immune modulation and nutritional recovery [8], [9]. The gene discussed is ALB; the disease is malignant colon neoplasm.